MAPT and Alzheimer disease: AD is a multifactorial neurodegenerative disorder associated with a gradual decline in cognitive function and characterized by extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tau tangles (NFT) [7,8].